tradingkey.logo

Island Pharmaceuticals Announces Purchase Of Galidesivir Antiviral Program From Biocryst Pharmaceuticals

ReutersJul 9, 2025 1:33 AM

- Island Pharmaceuticals Ltd ILA.AX:

  • ACQUISITION OF GALIDESIVIR ANTIVIRAL PROGRAM FROM BIOCRYST PHARMACEUTICALS

  • DEAL COMPLETED FOR BASE PURCHASE PRICE OF $550,000

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Related Articles

Tradingkey
KeyAI